98%
921
2 minutes
20
The two leading causes of chronic kidney disease (CKD) are excessive blood pressure and diabetes. Researchers worldwide utilize the rate of globular filtration and kidney inflammation biomarkers to identify chronic kidney disease that gradually reduces renal function. The mortality rate for CKD is high, and thus, a person with this illness is more likely to pass away at a younger age. Healthcare professionals must diagnose the various illnesses connected to this deadly disease as promptly as possible to lighten the impact of CKD. A quantum machine learning (QML) based technique is presented in this research to help with the early diagnosis and prognosis of CKD. The proposed research comprises four phases: data pre-processing, data augmentation, feature selection, and classification. In the first phase, Kalman filter and data normalization techniques are applied to handle the missing and noisy data. In the second phase, data augmentation uses sparse autoencoders to balance the data for smaller classes. In the third phase, LASSO shrinkage is used to select the significant features in the dataset. Variational Quantum classifiers, a supervised QML technique, are employed in the classification phase to classify chronic kidney diseases. The proposed system has been evaluated on the UCI dataset, which comprises 400 CKD patients in the early stages with 25 attributes. The suggested system was assessed using F1-score, precision, recall, and accuracy as evaluation metrics. With a 99.2% classification accuracy, it was found that this model performed better than the other traditional classifiers used for chronic kidney disease classification.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12190610 | PMC |
http://dx.doi.org/10.7717/peerj-cs.2789 | DOI Listing |
Arq Bras Cardiol
September 2025
Centro Hospitalar Universitário de Santo António, Porto - Portugal.
Arq Bras Cardiol
September 2025
Escola Bahiana de Medicina e Saúde Pública, Salvador, BA - Brasil.
Background: Chronic kidney disease (CKD) is associated with a higher prevalence of valvular diseases and increased mortality from cardiovascular causes. Factors that influence the genesis of cardiac valve calcification (CVC) in these patients are not well-defined.
Objective: To determine the risk factors for valvular calcification in patients with CKD.
Am J Physiol Cell Physiol
September 2025
Division of Gastroenterology & Hepatology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.
Chronic diarrhea is a frequent gastrointestinal complication in both type 1 (T1D) and type 2 diabetes (T2D), although the underlying mechanisms differ: T1D is linked to autonomic neuropathy and disrupted transporter regulation, while T2D is often linked to medications and intestinal inflammation. Using streptozotocin-induced mouse models of T1D and T2D, we observed increased luminal fluid in the small intestine of both. Given the role of Na⁺/H⁺ exchanger 3 (NHE3) in fluid absorption and its loss in most diarrheal diseases, we examined NHE3 expression across intestinal segments.
View Article and Find Full Text PDFAm J Hypertens
September 2025
Biopharmaceuticals, US Medical Affairs, Wilmington, AstraZeneca, United States.
Background: Excess aldosterone of > 15ng/dL, in the presence of low renin, is linked to hypertension (HTN) and chronic kidney disease (CKD). This study investigated the association of aldosterone dysregulation at lower plasma aldosterone levels (≥5ng/dL) with the risk of uncontrolled HTN and CKD prevalence.
Methods: Patient plasma aldosterone measurements obtained during 2013-2023 were identified in the TriNetX Dataworks-USA Network of electronic medical records.
J Nephrol
September 2025
Department of Psychology, Institute of Psychiatry, Psychology & Neuroscience, Health Psychology Section, King's College London, 5th Floor Bermondsey Wing, Guy's Campus, London Bridge, London, SE1 9RT, UK.
Background: Depression and anxiety are common in chronic kidney disease (CKD) and worsen clinical outcomes. Psycho-behavioural interventions offer a promising, non-pharmacological approach. However, most evidence comes from people with kidney failure with distinct treatment needs, limiting relevance to earlier stages of CKD, where timely support may enhance self-management and slow progression.
View Article and Find Full Text PDF